MarketCap
ProQR Therapeutics N.V. PRQR
€ 1.49
2.14%
Facebook
X
Telegram
ProQR Therapeutics N.V. P/CF | PRQR
P/CF Jährlich ProQR Therapeutics N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.07 | -3.31 | 8.95 | -1.62 | -2.64 | -3.99 | -6.62 | -15.9 | -2.43 | -2.64 | -4.81 | -14.2 | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.95 | -15.9 | -4.36 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Xeris Pharmaceuticals
XERS
|
33.8 | $ 10.13 | 11.56 % | $ 1.63 B |  USA |
 |
X4 Pharmaceuticals
XFOR
|
-2.09 | $ 2.9 | 2.47 % | $ 123 M | USA |
 |
Xencor
XNCR
|
-6.6 | $ 25.63 | 3.18 % | $ 1.9 B | USA |
 |
22nd Century Group
XXII
|
-0.0701 | $ 0.91 | 2.13 % | $ 168 K | USA |
 |
Zai Lab Limited
ZLAB
|
-143 | $ 25.62 | 5.3 % | $ 28.1 B |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
-1.53 | $ 2.78 | 10.32 % | $ 200 M | USA |
 |
Zoetis
ZTS
|
19.3 | $ 71.41 | 2.45 % | $ 31.7 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-2.57 K | $ 3.22 | 1.09 % | $ 20.6 B |  Australia |
 |
Dr. Reddy's Laboratories Limited
RDY
|
0.264 | $ 12.32 | 0.57 % | $ 10.3 B |  India |
 |
Mirati Therapeutics
MRTX
|
-4.49 | - | - | $ 3.3 B | USA |
 |
Gritstone Oncology
GRTS
|
-2.27 | - | 0.42 % | $ 213 M | USA |
 |
NexImmune
NEXI
|
-0.116 | - | 70.13 % | $ 4.12 M | USA |
 |
Harpoon Therapeutics
HARP
|
-0.242 | - | - | $ 763 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
-0.3 | - | -37.48 % | $ 476 K | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
-7.2 | - | -19.68 % | $ 18.4 M |  Canada |
 |
ObsEva SA
OBSV
|
-2.21 | - | -15.52 % | $ 10.5 M |  Schweiz |
 |
HOOKIPA Pharma
HOOK
|
-0.117 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
-0.953 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
60.5 | - | - | $ 109 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
-8.84 | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
4.5 | - | - | $ 154 M | USA |
 |
Oyster Point Pharma
OYST
|
-3.49 | - | - | $ 300 M | USA |
 |
Intercept Pharmaceuticals
ICPT
|
-26.4 | - | - | $ 643 M | USA |
 |
9 Meters Biopharma
NMTR
|
-0.47 | - | -42.97 % | $ 1.05 M | USA |
 |
Otonomy
OTIC
|
-3.01 | - | -1.96 % | $ 4.68 M | USA |
 |
Chinook Therapeutics
KDNY
|
-11.9 | - | - | $ 2.6 B | USA |
 |
Kaleido Biosciences
KLDO
|
-0.956 | - | -3.69 % | $ 12.4 M | USA |
 |
Kronos Bio
KRON
|
-0.882 | - | 1.49 % | $ 50.8 M | USA |
 |
Landos Biopharma
LABP
|
-2.35 | - | 0.58 % | $ 144 M | USA |
 |
PhaseBio Pharmaceuticals
PHAS
|
-2.42 | - | 7.4 % | $ 6.29 M | USA |
 |
Provention Bio
PRVB
|
-23.7 | - | - | $ 2.37 B | USA |
 |
Poseida Therapeutics
PSTX
|
-3.32 | - | - | $ 857 M | USA |
 |
PolarityTE
PTE
|
-0.191 | - | -0.82 % | $ 1.78 M | USA |
 |
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | USA |
 |
Reata Pharmaceuticals
RETA
|
-8.05 | - | - | $ 6.29 B | USA |
 |
Lumos Pharma
LUMO
|
-0.791 | - | - | $ 35.3 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
-10 | - | - | $ 23.9 M | USA |
 |
Satsuma Pharmaceuticals
STSA
|
-0.528 | - | -0.9 % | $ 36.5 M | USA |
|
89bio
ETNB
|
-2.65 | - | - | $ 1.55 B | USA |
 |
Syros Pharmaceuticals
SYRS
|
-1.51 | - | -8.44 % | $ 3.4 M | USA |
 |
SpringWorks Therapeutics
SWTX
|
-25.4 | - | - | $ 3.48 B | USA |
 |
Trevena
TRVN
|
-0.154 | - | -46.58 % | $ 31.8 M | USA |
 |
Oncorus
ONCR
|
-0.000139 | - | -8.54 % | $ 3.19 M | USA |
 |
OncoSec Medical Incorporated
ONCS
|
-0.55 | - | 31.87 % | $ 1.61 M | USA |
 |
Y-mAbs Therapeutics
YMAB
|
-13.8 | - | - | $ 382 M | USA |
 |
Oncternal Therapeutics
ONCT
|
-0.849 | - | -24.12 % | $ 1.56 M | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
-0.997 | - | -2.99 % | $ 2.47 M | USA |
 |
Albireo Pharma
ALBO
|
-5.09 | - | -0.23 % | $ 916 M | USA |
 |
BELLUS Health
BLU
|
-22.1 | - | - | $ 2.47 B | Canada |
 |
bluebird bio
BLUE
|
-0.0143 | - | - | $ 546 M | USA |